Compounds > 1-methyltryptophan
Page last updated: 2024-08-26

1-methyltryptophan and Central Nervous System Disease

1-methyltryptophan has been researched along with Central Nervous System Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dounay, AB; Tuttle, JB; Verhoest, PR1

Reviews

1 review(s) available for 1-methyltryptophan and Central Nervous System Disease

ArticleYear
Challenges and Opportunities in the Discovery of New Therapeutics Targeting the Kynurenine Pathway.
    Journal of medicinal chemistry, 2015, Nov-25, Volume: 58, Issue:22

    Topics: Animals; Antineoplastic Agents; Central Nervous System Diseases; Enzyme Inhibitors; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Kynurenine 3-Monooxygenase; Signal Transduction; Transaminases

2015